




- Full support End-to-End Management
- Setting Compliance Standards
- Experience in High-Risk Portfolio Experties

- Global Regulatory Coverage
- Clinical Trials
- Supply Chain Quality Management

- On-Site Supplier Audits
- Multiple Product Inspection Modes
- Global Reporting with Timely Efficiency
01
Clinical Trial Design
Protocol development
Statistical analysis plan (SAP)
Endpoint selection
Sample size calculation
02
Clinical Evaluation
Clinical Evaluation Report (CER) per MDR Annex XIV
Literature review
State-of-the-art (SOTA) analysis
03
Trial Management
Site selection & initiation
Monitoring
Data management
Safety reporting
04
Biostatistics
Statistical programming
Interim analysis
Final study report (FSR)
05
Regulatory Clinical Strategy
FDA IDE / IND
NMPA clinical trial approval
Clinical data for 510(k) / PMA / MDR / WHO PQ
06
Post-Market Clinical Follow-up (PMCF)
MDR PMCF plan & report
Real-world evidence (RWE) generation